Currently, there are 468.00M common shares owned by the public and among those 407.98M shares have been available to trade.
The company’s stock has a 5-day price change of -9.78% and 53.08% over the past three months. TOST shares are trading 109.58% year to date (YTD), with the 12-month market performance up to 149.32% higher. It has a 12-month low price of $15.14 and touched a high of $44.12 over the same period. TOST has an average intraday trading volume of 7.20 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.60%, 11.16%, and 41.26% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Toast Inc (NYSE: TOST) shares accounts for 69.98% of the company’s 468.00M shares outstanding.
It has a market capitalization of $21.74B and a beta (3y monthly) value of 1.94. The earnings-per-share (ttm) stands at -$0.13. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.64% over the week and 4.02% over the month.
Earnings per share for the fiscal year are expected to increase by 526.96%, and 36.25% over the next financial year. EPS should shrink at an annualized rate of -14.83% over the next five years, compared to -2.90% over the past 5-year period.
Looking at the support for the TOST, a number of firms have released research notes about the stock. DA Davidson stated their Neutral rating for the stock in a research note on December 05, 2024, with the firm’s price target at $44-$38. Goldman coverage for the Toast Inc (TOST) stock in a research note released on December 02, 2024 offered a Neutral rating with a price target of $45. Compass Point was of a view on November 20, 2024 that the stock is Buy, while Exane BNP Paribas gave the stock Neutral rating on November 20, 2024, issuing a price target of $37. Cleveland Research on their part issued Buy rating on September 27, 2024.